‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up
Author:
M.M. Folqué,J. Lozano,C. Riggioni,M. Piquer,M. Álvaro,A. Machinena,M.T. Giner,O. Domínguez,R.M. Jiménez-Feijoo,M. Dias da Costa,A.M. Plaza
Publication:
Allergologia et Immunopathologia
© 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.